The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $3.3 in the prior trading day, Medicus Pharma Ltd (NASDAQ: MDCX) closed at $3.03, down -8.18%. In other words, the price has decreased by -$8.18 from its previous closing price. On the day, 0.75 million shares were traded. MDCX stock price reached its highest trading level at $3.25 during the session, while it also had its lowest trading level at $2.98.
Ratios:
Our goal is to gain a better understanding of MDCX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.08.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 20 ’25 when VELOCITY FUND PARTNERS, LP sold 75,000 shares for $7.72 per share. The transaction valued at 578,940 led to the insider holds 3,248,741 shares of the business.
VELOCITY FUND PARTNERS, LP bought 118,000 shares of MDCX for $23,067,500 on May 20 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDCX now has a Market Capitalization of 48278200.
Stock Price History:
Over the past 52 weeks, MDCX has reached a high of $8.94, while it has fallen to a 52-week low of $1.80. The 50-Day Moving Average of the stock is -23.24%, while the 200-Day Moving Average is calculated to be -11.83%.
Shares Statistics:
The stock has traded on average 333.06K shares per day over the past 3-months and 704380 shares per day over the last 10 days, according to various share statistics. A total of 13.42M shares are outstanding, with a floating share count of 2.34M. Insiders hold about 80.22% of the company’s shares, while institutions hold 26.24% stake in the company. Shares short for MDCX as of 1749772800 were 111316 with a Short Ratio of 0.39, compared to 1747267200 on 269265. Therefore, it implies a Short% of Shares Outstanding of 111316 and a Short% of Float of 1.17.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The market rating for Medicus Pharma Ltd (MDCX) is a result of the insights provided by 2 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.12 and low estimates of -$0.31.
Analysts are recommending an EPS of between -$0.55 and -$1.46 for the fiscal current year, implying an average EPS of -$1.0. EPS for the following year is -$0.77, with 2.0 analysts recommending between -$0.43 and -$1.12.
